PCSK9 inhibitors and cardiovascular outcomes

  • Daniel Steffens, Peter Bramlage, Céline Scheeff, Mario Kasner, Adel Hassanein, Julian Friebel, Ursula Rauch-Kröhnert
  • Expert Opinion on Biological Therapy, October 2019, Taylor & Francis
  • DOI: 10.1080/14712598.2020.1677604

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Peter Bramlage and Professor Ursula Rauch